889 research outputs found
Cooking traces on Copper Age pottery from central Italy: An integrated approach comprising use wear analysis, spectroscopic analysis and experimental archaeology
This contribution discusses the results of an integrated approach of use wear analysis, spectroscopic analysis and experimental archaeology, applied for the investigation of the actual use of selected ceramic vessels, taken from domestic Copper Age contexts in the modern Rome area. This study is based upon the consideration of a vessel as a tool, used during everyday life and thus reflecting human activities and social behaviours. To this end, the paper here presented proposes an interpretation of the actual use activities which led to the modification of prehistoric vessels. The methodology of this study integrates the traditional approach to ceramic use wear studies, based on experimental and ethnoarchaeological studies, with principles of tribology, along with the application of a dedicated experimental framework which enabled the development of a detailed collection of comparative use wear. Moreover, the application of spectroscopic analysis provided preliminary data related to the charred encrustations found inside the archaeological specimens. These data, when combined with use wear, palaeobotanical remains and archaeological preserved structures, aided interpretation of the archaeological ceramic vessels as cooking pots
Influence of three species of arbuscular mycorrhizal fungi on the persistence of aromatic hydrocarbons in contaminated substrates
Milk-derived bioactive peptides exhibit antioxidant activity through the Keap1-Nrf2 signaling pathway
Bioactive peptides are relevant nutritional factors that exhibit many functions including antioxidant, anti-hypertensive, anticancer and antimicrobial properties. In this paper, four synthetic peptides ARHPHPHLSFM (A-11-M), AVPYPQR (A-7-R), NPYVPR (N-6-R) and KVLPVPEK (K-8-K) with sequences present in milk proteinswere examined for their antioxidant properties. The compounds show moderate free radical scavenging activityin the ABTS and crocin assays (A-7-R and N-6-R) and lipid peroxidation inhibition in Caco-2 cells (N-6-R and K-8-K). All peptides, in particular K-8-K, activate the Keap1-Nrf2 system by allowing the translocation of the tran-scription factor Nrf2 from the cytosol to nucleus. This activation triggers the overexpression of the antioxidantenzymes Trx1, TrxR1, GR, NQO1 and SOD1. Furthermore, molecular modeling shows that K-8-K is able to hinderthe interaction of Nrf2 with Keap1. The reported results show that the antioxidant action in cells of thesebioactive peptides is mostly due to the activation of Keap1-Nrf2 signaling pathwa
Passive and catalytic antibodies and drug delivery
Antibodies are one of the most promising components of the biotechnology repertoire for the purpose of drug delivery. On the one hand, they are proven agents for cell-selective delivery of highly toxic agents in a small but expanding number of cases. This technology calls for the covalent attachment of the cytotoxin to a tumor-specific antibody by a linkage that is reversible under appropriate conditions (antibody conjugate therapy, ACT —"passive delivery”). On the other hand, the linker cleavage can be accomplished by a protein catalyst attached to the tumor-specific antibody ("catalytic delivery”). Where the catalyst is an enzyme, this approach is known as antibody-directed enzyme prodrug therapy (ADEPT). Where the transformation is brought about by a catalytic antibody, it has been termed antibody-directed abzyme prodrug therapy (ADAPT). These approaches will be illustrated with emphasis on how their demand for new biotechnology is being realized by structure-based protein engineerin
Impact of Phosphatic Nutrition on Growth Parameters and Artemisinin Production in Artemisia annua Plants Inoculated or Not with Funneliformis mosseae
Artemisia annua L. is a medicinal plant appreciated for the production of artemisinin, a molecule used for malaria treatment. However, the natural concentration of artemisinin in planta is low. Plant nutrition, in particular phosphorus, and arbuscular mycorrhizal (AM) fungi can affect both plant biomass and secondary metabolite production. In this work, A. annua plants were inoculated or not with the AM fungus Funneliformis mosseae BEG12 and cultivated for 2 months in controlled conditions at three different phosphatic (P) concentrations (32, 96, and 288 µM). Plant growth parameters, leaf photosynthetic pigment concentrations, artemisinin production, and mineral uptake were evaluated. The different P levels significantly affected the plant shoot growth, AM fungal colonization, and mineral acquisition. High P levels negatively influenced mycorrhizal colonization. The artemisinin concentration was inversely correlated to the P level in the substrate. The fungus mainly affected root growth and nutrient uptake and significantly lowered leaf artemisinin concentration. In conclusion, P nutrition can influence plant biomass production and the lowest phosphate level led to the highest artemisinin concentration, irrespective of the plant mineral uptake. Plant responses to AM fungi can be modulated by cost–benefit ratios of the mutualistic exchange between the partners and soil nutrient availability
Phosphatic nutrition affects biomass production, photosynthetic pigment concentration and artemisinin biosynthesis in A. annua plants grown in presence or not of F. mosseae
The effect of timing and composition of gestational weight gain in obese pregnant women on infant birth weight: A prospective cohort study.
Introduction: CK2 is a protein kinase implicated in several essential cellular
processes, over-expressed in cancer and described to regulate insulin
signaling cascade. Recently CK2 has been described to negatively regulate
thermogenesis (Shinoda K et al, 2015, Cell Metabolism) and to inhibit
insulin release (Rossi M et al, 2015, PNAS). Nevertheless, the role of CK2
in adipose tissue (AT) and its involvement in human obesity development
and therapy has been poorly investigated.
Methods: Our multi-disciplinary team performed biochemical analysis of
signaling pathways by WB and in vitro kinase activity assays, and glucose
handling studies using glucose uptake assay and IF in adipocyte cultures
and glucose and insulin tolerance test in mice. Moreover we quantify CK2
expression/activity in human AT specimens of 27 obese patients, clinically
characterized, in 12 obese patients underwent relevant weight loss and 11
normal-weight controls.
Results: We proved that CK2 amount and activity were not influenced
by insulin stimulation and that CK2 activity was efficiently inhibited by
specific inhibitors, structurally unrelated. We worked with CX-4945, a
CK2 inhibitor currently used in cancer clinical trials, using the minimal
concentration (2.5 \u192
dM) and pre-treatment time (1hr) able to efficiently
inhibit CK2 activity, avoiding any cytotoxic effect. Pharmacological
inhibition of CK2 did not significantly affect in vitro adipogenic differentiation
or expression profiling of mature adipocytes. Conversely, we
showed that in human and murine adipocytes CK2-inhibition decreases
the insulin-induced glucose uptake by counteracting Akt-signaling and
GLUT4-translocation to the plasma membrane. We compared CK2 expression
and activity in different mouse tissues highlighted that white
skeletal muscle fibres and liver contained the highest quantity of this kinase.
CK2 was expressed more in brown AT than in white AT depots. We
show that CK2 promotes insulin-signaling in mouse AT, liver and skeletal
muscle and that in vivo acute treatment with CX-4945 impairs glucose-
tolerance in mice. Studies in tissues of ob/ob and db/db mice highlights
an up-regulation of CK2 expression and activity only in WAT. CK2
hyper-activation is strongly evident also in SAT and VAT of obese patients
and weight loss obtained by bariatric surgery or hypocaloric diet reverts
CK2 up-regulation to normal level.
Conclusion: We show that CK2 is involved in insulin sensitivity, glucose
handling and remodeling of WAT. Moreover we identify CK2 hyper-activation
as a hallmark of human obesity, suggesting a new potential therapeutic
target for metabolic diseases
- …